Mutations at K291 and K292 (His-K291R-p53 and His-K292R-p53) further attenuated the inhibitory effects of Flag-FBXO33 on p53, resulting in significantly enhanced anti-cancer activity of p53 in these mutant groups compared to His-WT-p53. Here, TP53 is linked to cancer.